OVARIAN CANCER: NATURAL HISTORY AND METASTATIC PATTERN

Amadori D., MD, Sansoni E.,MD, Amadori A., MD

Department of Medical Oncology- Pierantoni Hospital, Via Forlanini, 34 47100 FORLI', Italy

Received 9/16/96; Accepted 12/6/96; On-line 01/01/97

4. REFERENCES

1. Gallion, H.H. Pieretti, M. De Priest, P.D. van Nagell, J.R.: The molecular basis of ovarian cancer. Cancer Suppl 76, 1992-7 (1995)

2. Pettersson, F.: Annual report of the results of treatment in gynecologic cancer. International Federation of Gynecology and Obstetrics (FIGO) (1988)

3. Jacobs, I.J. Oram, D.A.: Potential screening tests for ovarian cancer. In: Ovarian Cancer Biologic and therapeutic challenges. Eds: Sharp, C.F. Mason, W.P. Leake, R. Chapman and Hall, London (1990)

4. Platz, C.E. Benda, J.A.: Female genital tract cancer. Cancer 75, 270-94 (1995)

5. Sigurdsson, K. Alm, P. Gullberg, B.: Prognostic factors in malignant epithelial ovarian tumors. Gynecol Oncol 15, 370-80 (1983)

6. Hightower, R.D. Nguyen, H.N. Averette, H.E. Hoskins, W. Harrison, T. Steren A.: National survey of ovarian carcinoma IV: Patterns of care and related survival for older patients. Cancer 73, 377-83 (1994)

7. Berek,J.S. Hacker, N.F.: Ovarian and fallopian tubes. In: Cancer Treatment Eds: Haskell, C.M. W.B. Saunders, Philadelphia (1990)

8. Voest, E.E. van Houwelingen, H.C. Neijt, J.P.: A meta-analysis of prognostic factors in advanced ovarian cancer with median survival measured with log (relative risk) as main objectives. Eur J Cancer Clin Oncol 25:711 (1989)

9. van Houwelingen, J.C. Bokkel Huinink, W. van der Burg, A.T.M. Neijt, J.P.: Predictability of the survival of patients with ovarian cancer. J Clin Oncol 7: 759 (1989)

10. Filmus, J. Buic, R.:Stability of c-K-ras amplification during progression in a patient with adenocarcinoma of the ovary. Cancer Res 45:4468-72 (1985)

11. Zhou, D. Gonzales-Cadaviv, N. Ahuja, H. Battifora, H, Moore, G.E. Cline, M.J.: A unique pattern of proto-oncogene abnormalities in ovarian adenocarcinomas. Cancer 62, 1573-76 (1988)

12. Fukumoto, M. Estensen, R. Sha, L. Oakley, G.J. Twiggs, L.B. Adcock, L.L. Carson, L.F. Roninson, I.B.: Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinoma by a modified in-gel renaturarion assay. Cancer Res 49: 1693-97 (1989)

13. Perez, R.P. Godwin, A.K. Hamilton, T.C. Ozols, R.F.: Ovarian cancer biology. Semin Oncol 18, 186-204 (1991)

14. Rodenburg, C. Koelma, I. Nap, M.: Immunohistochemical detection of the ras oncogene product p21 in advanced ovarian cancer: lack of correlation with clinical outcome. Arch Pathol Lab Med 112:151-54 (1988)

15. Levesque, M.A. Katsaros, D. He, YU. Zola, P. Sismondi, P. Giardina, G. Diamandis E.P.D.: Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma. Cancer 75: 1327-1338 (1995)

16. Pfisterer, J. Kommoss, F. Sauerbrei W. Renz, H. du Bois, A. Kiechle-Schwartz, M. Pfleiderer, A.: Cellular DNA content and survival in advanced ovarian carcinoma. Cancer 74: 2509-15 (1994)

17. Leake, R.E. Owens, O.: The prognostic value of steroid receptors, growth factors and growth factor receptors in ovarian cancer. In: Ovarian cancer: Biologic and therapeutic challenges. Eds: Sharp, C.F. Mason, W.P. Leake, R. Chapman and Hall, London (1990)

18. Baker, T.R. Piver, M.S. Hempling, R.E.: Long term survival by cytoreductive surgery to less than 1 cm., induction weekly cisplatin and monthly cisplatin, doxorubicin and cyclophosphamide therapy in advanced ovarian adenocarcinoma. Cancer 74, 656-63 (1994)

19. Young, R.C. Walton, L.A. Ellenberg, S.S. Homesley, H.D. Wilbanks, G.D. Decker, D.G. Miller, A. Park, R. Major, F.: Adjuvant therapy in stage I and stage II epithelial ovarian cancer. N Eng J Med 322, 1021-27 (1990)

20. Bolis, G. Colombo, G. Pecorelli, Torri, V. Marsoni, S. Bonazzi, C. Chiari, S. Favalli, G. Mangili, G. Presti, M. Zanaboni, F. Mangioni, C.: Adjuvant treatment for early epithelial ovarian cancer: results of two randomized clinical trials comparing cisplatin to no further treatment or chromic phoshate (³² P). Ann Oncol. 6, 887-93 (1995)

21. Pickel, H. Lahousen, M. Girardi, F. Tamussino, H. Stettner, H.: Intraperitoneal and retroperitoneal spread of ovarian cancer. In: Ovarian Cancer: Biologic and Therapeutic challenges. Eds: Sharp, C.F. Mason, W.P. Leake, R. eds., London: Chapman and Hall (1990)

22. Dauplat, J. Hacker, N.F. Nieberg, R.K. Berek, J.S. Rose, T.P. Sagae, S.: Distant metastases in epithelial ovarian carcinoma. Cancer 60: 1561-1566 (1987)